nodes	percent_of_prediction	percent_of_DWPC	metapath
Quinapril—SLC15A1—epithelium—cervical cancer	0.0523	0.0809	CbGeAlD
Quinapril—SLC15A1—renal system—cervical cancer	0.0485	0.0751	CbGeAlD
Quinapril—SLC15A1—endometrium—cervical cancer	0.0469	0.0726	CbGeAlD
Quinapril—SLC15A1—mammalian vulva—cervical cancer	0.0454	0.0702	CbGeAlD
Quinapril—ACE—epithelium—cervical cancer	0.0375	0.058	CbGeAlD
Quinapril—ACE—decidua—cervical cancer	0.0354	0.0548	CbGeAlD
Quinapril—SLC15A1—vagina—cervical cancer	0.0351	0.0544	CbGeAlD
Quinapril—ACE—renal system—cervical cancer	0.0348	0.0538	CbGeAlD
Quinapril—ACE—endometrium—cervical cancer	0.0336	0.052	CbGeAlD
Quinapril—ACE—mammalian vulva—cervical cancer	0.0325	0.0503	CbGeAlD
Quinapril—SLC15A2—uterine cervix—cervical cancer	0.0324	0.0502	CbGeAlD
Quinapril—SLC15A2—renal system—cervical cancer	0.0303	0.0469	CbGeAlD
Quinapril—SLC15A2—endometrium—cervical cancer	0.0293	0.0454	CbGeAlD
Quinapril—ACE—female reproductive system—cervical cancer	0.0278	0.0431	CbGeAlD
Quinapril—ACE—female gonad—cervical cancer	0.0253	0.0392	CbGeAlD
Quinapril—Benazepril—MTHFR—cervical cancer	0.025	1	CrCbGaD
Quinapril—SLC15A2—female reproductive system—cervical cancer	0.0243	0.0376	CbGeAlD
Quinapril—SLC15A2—female gonad—cervical cancer	0.0221	0.0342	CbGeAlD
Quinapril—SLC15A2—vagina—cervical cancer	0.022	0.034	CbGeAlD
Quinapril—ACE—lymph node—cervical cancer	0.0163	0.0252	CbGeAlD
Quinapril—Anaphylactoid reaction—Topotecan—cervical cancer	0.0156	0.0474	CcSEcCtD
Quinapril—SLC15A2—lymph node—cervical cancer	0.0142	0.022	CbGeAlD
Quinapril—Infestation—Topotecan—cervical cancer	0.0116	0.0353	CcSEcCtD
Quinapril—Infestation NOS—Topotecan—cervical cancer	0.0116	0.0353	CcSEcCtD
Quinapril—Hepatobiliary disease—Topotecan—cervical cancer	0.011	0.0334	CcSEcCtD
Quinapril—Pharyngitis—Topotecan—cervical cancer	0.0104	0.0315	CcSEcCtD
Quinapril—Angiopathy—Topotecan—cervical cancer	0.00947	0.0288	CcSEcCtD
Quinapril—Immune system disorder—Topotecan—cervical cancer	0.00943	0.0287	CcSEcCtD
Quinapril—Mediastinal disorder—Topotecan—cervical cancer	0.00941	0.0286	CcSEcCtD
Quinapril—Alopecia—Topotecan—cervical cancer	0.00922	0.028	CcSEcCtD
Quinapril—Back pain—Topotecan—cervical cancer	0.00879	0.0267	CcSEcCtD
Quinapril—Ill-defined disorder—Topotecan—cervical cancer	0.00843	0.0256	CcSEcCtD
Quinapril—Angioedema—Topotecan—cervical cancer	0.0083	0.0252	CcSEcCtD
Quinapril—Malaise—Topotecan—cervical cancer	0.0082	0.0249	CcSEcCtD
Quinapril—Cough—Topotecan—cervical cancer	0.00793	0.0241	CcSEcCtD
Quinapril—Arthralgia—Topotecan—cervical cancer	0.00774	0.0235	CcSEcCtD
Quinapril—Chest pain—Topotecan—cervical cancer	0.00774	0.0235	CcSEcCtD
Quinapril—Myalgia—Topotecan—cervical cancer	0.00774	0.0235	CcSEcCtD
Quinapril—Unspecified disorder of skin and subcutaneous tissue—Topotecan—cervical cancer	0.00768	0.0234	CcSEcCtD
Quinapril—Discomfort—Topotecan—cervical cancer	0.00764	0.0232	CcSEcCtD
Quinapril—Anaphylactic shock—Topotecan—cervical cancer	0.00742	0.0225	CcSEcCtD
Quinapril—Infection—Topotecan—cervical cancer	0.00737	0.0224	CcSEcCtD
Quinapril—Nervous system disorder—Topotecan—cervical cancer	0.00727	0.0221	CcSEcCtD
Quinapril—Thrombocytopenia—Topotecan—cervical cancer	0.00726	0.0221	CcSEcCtD
Quinapril—Skin disorder—Topotecan—cervical cancer	0.0072	0.0219	CcSEcCtD
Quinapril—Hyperhidrosis—Topotecan—cervical cancer	0.00717	0.0218	CcSEcCtD
Quinapril—Musculoskeletal discomfort—Topotecan—cervical cancer	0.00676	0.0205	CcSEcCtD
Quinapril—Paraesthesia—Topotecan—cervical cancer	0.00666	0.0202	CcSEcCtD
Quinapril—Dyspnoea—Topotecan—cervical cancer	0.00661	0.0201	CcSEcCtD
Quinapril—Dyspepsia—Topotecan—cervical cancer	0.00653	0.0198	CcSEcCtD
Quinapril—Gastrointestinal disorder—Topotecan—cervical cancer	0.0064	0.0195	CcSEcCtD
Quinapril—Fatigue—Topotecan—cervical cancer	0.00639	0.0194	CcSEcCtD
Quinapril—Constipation—Topotecan—cervical cancer	0.00634	0.0193	CcSEcCtD
Quinapril—Feeling abnormal—Topotecan—cervical cancer	0.00611	0.0186	CcSEcCtD
Quinapril—Gastrointestinal pain—Topotecan—cervical cancer	0.00606	0.0184	CcSEcCtD
Quinapril—Abdominal pain—Topotecan—cervical cancer	0.00586	0.0178	CcSEcCtD
Quinapril—Asthenia—Topotecan—cervical cancer	0.00532	0.0162	CcSEcCtD
Quinapril—Pruritus—Topotecan—cervical cancer	0.00525	0.0159	CcSEcCtD
Quinapril—Diarrhoea—Topotecan—cervical cancer	0.00507	0.0154	CcSEcCtD
Quinapril—Dizziness—Topotecan—cervical cancer	0.0049	0.0149	CcSEcCtD
Quinapril—Vomiting—Topotecan—cervical cancer	0.00472	0.0143	CcSEcCtD
Quinapril—Rash—Topotecan—cervical cancer	0.00468	0.0142	CcSEcCtD
Quinapril—Dermatitis—Topotecan—cervical cancer	0.00467	0.0142	CcSEcCtD
Quinapril—Headache—Topotecan—cervical cancer	0.00465	0.0141	CcSEcCtD
Quinapril—Nausea—Topotecan—cervical cancer	0.00441	0.0134	CcSEcCtD
